Goserelin (Zoladex®)

Common name: Goserelin
Brand name: Zoladex®
 

What is Goserelin?

Goserelin is a hormonal therapy used to treat advanced prostate cancer by blocking the production or action of luteinizing hormone releasing hormone (LHRH) which reduces the levels of testosterone in the body.

Goserelin is used:
  • in the palliative treatment of patients with hormone-dependent advanced prostate cancer.
  • in combination with non-steroidal anti-androgens and radiation therapy for treating locally advanced prostate cancer.
  • as an adjuvant hormone therapy to external beam irradiation for locally advanced prostate cancer.


How is Goserelin administered?

Goserelin is administered by subcutaneous injection.


What are possible side effects of this treatment?

Everyone responds differently to hormone therapy – some experience many side effects while others experience very few. Below are some side effects experienced by those who received goserelin. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Breast tenderness
  • Changes to mood
  • Decreased sex drive (low libido)
  • Fatigue
  • Hot flashes
  • Impotence
  • Nausea / vomiting
  • Osteoporosis (weakened bones)
  • Rashes
  • Sore joints
  • Weight gain
 

Is Goserelin covered in my province or territory?*

Goserelin is covered by all provincial/territorial drug programs.


*Source: http://drugcoverage.ca/en-ca/search-results.aspx?ID=19055
Last Reviewed: July 2017

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive